“…In this context, pharmacological compounds repressing striatopallidal activity appear as promising candidates for the treatment of OUD, possibly by restoring "liking" (121) for non-drug, notably social, stimuli. More broadly, opiate addiction sharing striking phenotypic and neurobiological features with other diseases considered as "reward deficiency syndromes", such as autism or depression (27,116,122,123), our work opens promising avenues towards the development of common therapeutic strategies for these pathologies. suppressed feeding test, chronic mGluR4 PAM administration normalized latency to feed and food intake in morphine abstinent animals since the lower dose (abstinence: F1,56=11.3, p<0.01; dose: F2,56=15.4, p<0.0001; abstinence x dose: F2,57=10.5, p<0.001), with no effect in vehicle or cocaine abstinent animals.…”